| Katelyn Marie Bonar Zachau, DO | |
|
315 E Center St, Manchester, CT 06040-5251 | |
| (860) 533-0179 | |
| Not Available |
| Full Name | Katelyn Marie Bonar Zachau |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 11 Years |
| Location | 315 E Center St, Manchester, Connecticut |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1932543592 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 1.055300 (Connecticut) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Manchester Memorial Hospital | Manchester, CT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Prospect Ct Medical Foundation Inc | 7416244496 | 267 |
News Archive
Medivir AB (STO:MVIR-B) (OMX: MVIR), announces the initiation of a phase IIa trial in chronic genotype 1 hepatitis C infected patients to evaluate the efficacy, safety and tolerability of a 12-week combination therapy of simeprevir, TMC647055 and JNJ56914845, a NS5A replication complex inhibitor.
Keryx Biopharmaceuticals, Inc., announced today that its Japanese partner, Japan Tobacco Inc. and Torii Pharmaceutical Co., Ltd., has announced positive top-line results from a Phase 3 study of ferric citrate in Japan for the treatment of hyperphosphatemia in end-stage renal disease patients on hemodialysis.
Last fall there was a mad rush for the HINI vaccine for the deadly swine flu that had gripped countries across the world. H1N1 flu has killed about 12,000 Americans and put 265,000 into the hospital in the last pandemic. This year has seen a few signs of seasonal flu, which kills about 36,000 people in the United States each year and puts 200,000 in the hospital.
Rexahn Pharmaceuticals, Inc. a clinical stage biopharmaceutical company developing best-in-class therapeutics for the treatment of cancer, is providing an overview of its three clinical development programs and Year for the year ended December 31, 2013.
American over-65s scored significantly better than their English counterparts at a memory and awareness test. The authors of the research, published in the open access journal BMC Geriatrics, suggest that differences in relative levels of depression, education, and the aggressiveness of treatment for heart disease may be to blame.
› Verified 4 days ago
| Entity Name | Prospect Ct Medical Foundation Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144677568 PECOS PAC ID: 7416244496 Enrollment ID: O20160919001322 |
News Archive
Medivir AB (STO:MVIR-B) (OMX: MVIR), announces the initiation of a phase IIa trial in chronic genotype 1 hepatitis C infected patients to evaluate the efficacy, safety and tolerability of a 12-week combination therapy of simeprevir, TMC647055 and JNJ56914845, a NS5A replication complex inhibitor.
Keryx Biopharmaceuticals, Inc., announced today that its Japanese partner, Japan Tobacco Inc. and Torii Pharmaceutical Co., Ltd., has announced positive top-line results from a Phase 3 study of ferric citrate in Japan for the treatment of hyperphosphatemia in end-stage renal disease patients on hemodialysis.
Last fall there was a mad rush for the HINI vaccine for the deadly swine flu that had gripped countries across the world. H1N1 flu has killed about 12,000 Americans and put 265,000 into the hospital in the last pandemic. This year has seen a few signs of seasonal flu, which kills about 36,000 people in the United States each year and puts 200,000 in the hospital.
Rexahn Pharmaceuticals, Inc. a clinical stage biopharmaceutical company developing best-in-class therapeutics for the treatment of cancer, is providing an overview of its three clinical development programs and Year for the year ended December 31, 2013.
American over-65s scored significantly better than their English counterparts at a memory and awareness test. The authors of the research, published in the open access journal BMC Geriatrics, suggest that differences in relative levels of depression, education, and the aggressiveness of treatment for heart disease may be to blame.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Katelyn Marie Bonar Zachau, DO 75 Hockanum Blvd, Apt. 1821, Vernon, CT 06066-4056 Ph: (919) 724-5876 | Katelyn Marie Bonar Zachau, DO 315 E Center St, Manchester, CT 06040-5251 Ph: (860) 533-0179 |
News Archive
Medivir AB (STO:MVIR-B) (OMX: MVIR), announces the initiation of a phase IIa trial in chronic genotype 1 hepatitis C infected patients to evaluate the efficacy, safety and tolerability of a 12-week combination therapy of simeprevir, TMC647055 and JNJ56914845, a NS5A replication complex inhibitor.
Keryx Biopharmaceuticals, Inc., announced today that its Japanese partner, Japan Tobacco Inc. and Torii Pharmaceutical Co., Ltd., has announced positive top-line results from a Phase 3 study of ferric citrate in Japan for the treatment of hyperphosphatemia in end-stage renal disease patients on hemodialysis.
Last fall there was a mad rush for the HINI vaccine for the deadly swine flu that had gripped countries across the world. H1N1 flu has killed about 12,000 Americans and put 265,000 into the hospital in the last pandemic. This year has seen a few signs of seasonal flu, which kills about 36,000 people in the United States each year and puts 200,000 in the hospital.
Rexahn Pharmaceuticals, Inc. a clinical stage biopharmaceutical company developing best-in-class therapeutics for the treatment of cancer, is providing an overview of its three clinical development programs and Year for the year ended December 31, 2013.
American over-65s scored significantly better than their English counterparts at a memory and awareness test. The authors of the research, published in the open access journal BMC Geriatrics, suggest that differences in relative levels of depression, education, and the aggressiveness of treatment for heart disease may be to blame.
› Verified 4 days ago
Dr. Quazi T Islam, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 515 Middle Tpke W, Manchester, CT 06040 Phone: 860-533-4176 | |
Dr. Barbara Louise Phillips, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 574 Middle Tpke E, Manchester, CT 06040 Phone: 860-646-4334 Fax: 860-646-7020 | |
Gordon Brodie, M.D Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 375 E Center St, Manchester, CT 06040 Phone: 860-646-0166 Fax: 860-643-7574 | |
Dr. Sheenay Kendra Pryce, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 515 Middle Tpke W, Manchester, CT 06040 Phone: 860-533-4175 | |
Dr. Brad Brooks, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 315 E Center St, Manchester, CT 06040 Phone: 860-533-0179 Fax: 866-603-4163 | |
Mr. Serge Peter Poulin, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 315 E. Center St, Manchester, CT 06040 Phone: 860-649-6900 Fax: 860-647-0469 | |
Kelli Harper, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 71 Haynes St, Manchester, CT 06040 Phone: 860-646-1222 |